RosVivo Therapeutics
Reno, US · Founded 2021 · Nevada corporation
Founders & leadership
SR
Seungil RoNamed on SEC filing
SM
Sandra M. PoudrierNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 round · 2021
▶$5.5MraisedJun 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$5.5MraisedJun 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Seungil RoExecutive Officer
- Sandra M. PoudrierExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- Minimum investment
- $5.5M
- Finders' fees
- $163.6K
- First sale
- May 2021
- Incorporated
- Corporation, Nevada, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has RosVivo Therapeutics raised?
- RosVivo Therapeutics has disclosed $5.5M raised across 1 round.
- Where is RosVivo Therapeutics headquartered?
- RosVivo Therapeutics is headquartered in Reno, US.